BCM
TVRD

Bridgeway Capital Management’s Tvardi Therapeutics TVRD Stock Holding History

Bridgeway Capital Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,922
Closed -$105K – 1385
2023
Q4 		$105K Hold
3,922
– – ﹤0.01% 1231
2023
Q3 		$237K Buy
+3,922
New +$368K 0.01% 1064
2018
Q4 		– Sell
-278
Closed -$240K – 1476
2018
Q3 		$240K Sell
278
-278
-50% -$201K ﹤0.01% 1289
2018
Q2 		$383K Sell
556
-972
-64% -$494K ﹤0.01% 1201
2018
Q1 		$681K Hold
1,528
– – 0.01% 987
2017
Q4 		$673K Hold
1,528
– – 0.01% 997
2017
Q3 		$753K Sell
1,528
-694
-31% -$348K 0.01% 951
2017
Q2 		$1.23M Sell
2,222
-1,763
-44% -$1.12M 0.01% 746
2017
Q1 		$2.64M Hold
3,985
– – 0.03% 475
2016
Q4 		$1.33M Sell
3,985
-1,894
-32% -$608K 0.02% 696
2016
Q3 		$1.77M Buy
5,879
+2,222
+61% +$482K 0.03% 572
2016
Q2 		$633K Buy
3,657
+2,022
+124% +$440K 0.01% 946
2016
Q1 		$366K Sell
1,635
-409
-20% -$122K 0.01% 1159
2015
Q4 		$1.24M Hold
2,044
– – 0.02% 660
2015
Q3 		$1.05M Hold
2,044
– – 0.02% 727
2015
Q2 		$894K Buy
2,044
+409
+25% +$158K 0.02% 837
2015
Q1 		$592K Buy
1,635
+663
+68% +$251K 0.01% 1013
2014
Q4 		$349K Buy
+972
New +$313K 0.01% 1181

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Bridgeway Capital Management's TVRD Position: Q1 2024 in Review

Bridgeway Capital Management sold out of Tvardi Therapeutics (TVRD) in Q1 2024, closing a stake of 3,922 shares — an estimated $105K sold.

Bridgeway Capital Management first reported a position in TVRD in Q4 2014 and held it in 18 quarters. The position peaked at $2.64M in Q1 2017. 97 funds tracked by Wall St. Rank hold TVRD as of Q1 2024.

  • Bridgeway Capital Management reported no remaining Tvardi Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 3,922 Tvardi Therapeutics shares in Q1 2024, an estimated $105K.
  • Bridgeway Capital Management first reported a position in Tvardi Therapeutics in Q4 2014 and held it in 18 quarters.
  • Bridgeway Capital Management's Tvardi Therapeutics position peaked at $2.64M in Q1 2017.
  • 97 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2024.

Based on Bridgeway Capital Management's 13F filing for Q1 2024, filed 15 May 2024.